Douglas Hausner

CRB Group
Life Sciences SME/ OSD Specialist
Douglas B. Hausner, PhD, is currently a Life Sciences SME/OSD Specialist at CRB. He brings more than a decade of pharmaceutical process experience to help lead complex large scale customer programs. He has been an ISPE member since 2011.

Related Articles

ICH Q13 and What Is Next for Continuous Manufacturing
Features
ICH Q13 and What Is Next for Continuous Manufacturing

The creation of a new ICH guidance document, Q13,International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. “ICH Harmonised Tripartite Guideline Q13: Continuous Manufacturing of Drug Substances and Drug Products.” Published July 2021.